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Abstract Early recognition of patients at increased cardiovascular risk is a major challenge. The surface
electrocardiogram provides a useful platform and it has been used to propose several indexes. T
wave axis abnormality is associated with an increased risk of cardiovascular mortality, independently
of other risk factors and can be associated with the presence of the metabolic syndrome (MetS). We
assessed the prevalence of T axis abnormalities and its relationship with MetS and its components in
a large population of Italian adults. Data concerning 11,143 women (54±11years) and 9742 men
(55±11years) randomly recruited from a general population (Moli-sani cohort) were analyzed. After
excluding subjects with incomplete data and with history of cardiac disease or left ventricular
hypertrophy, T-wave axis was normal in 74.5% of men and 80.9% of women, borderline in 23.6%
and 17.3% and abnormal in 1.9% and 1.8%. In subjects with MetS, the prevalence of borderline or
abnormal T-wave axis deviation was higher than in subjects without MetS (in men: 26.6% vs. 22.1%
and 2.5% vs. 1.7%; in women: 25% vs. 15% and 2.4% vs. 1.6%, respectively for borderline and
abnormal levels, pb0.0001). Each component of MetS increased the odds of having borderline or
abnormal T-wave axis deviation by 1.21 in men and 1.31 in women. T wave axis deviation is
associated with MetS and its individual components. These findings confirm previous reported
results, expanding them to a large and representative sample of European population of Caucasian
ethnicity.
© 2012 Elsevier Inc. All rights reserved.
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Introduction
Preclinical diagnosis of cardiovascular disease has always
been a difﬁcult task; many researchers tried to ﬁnd a speciﬁc
marker to bridge epidemiology and clinical practice. While
different markers have been proposed and compared, elec-
trocardiography, together with microalbuminuria, are con-
sidered among the most cost effective. Several authors tried
to introduce robust and reproducible indexes for both early
diagnostic and prognostic purposes. QT/QTc duration, left
ventricular hypertrophy, ventricular strain, and T-wave
alternans seem to be effective markers, although a consensus
on a speciﬁc marker has not been reached. Indeed, many of
the proposed parameters seem effective on selected patients,
but remain either difﬁcult to measure and/or complex to
compare, with a low reproducibility, and not easy to be
standardised because of a high intrinsic variability.1,2 As a
result of this uncertainty, qualitative parameters, still
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effective to better stratify populations, as Minnesota Code, are
frequently preferred to more quantitative indexes of preclin-
ical disease.3
T-wave axis, as derived by the 12 lead electrocardiogram,
has been analysed and compared with other electrocardio-
graphic parameters and traditional risk factors to assess as
indicators of risk of cardiac events in elderly people from the
Rotterdam Heart study, in a prospective study with a 4years
follow-up.4 The presence of a signiﬁcant shift in the T-wave
axis, derived from both the frontal and horizontal plane leads
resulted as the most predictive ECG index, both for fatal and
non fatal events, maintaining its predictive value even after
correction for others ECG indexes. After stratiﬁcation for
traditional risk factors it was still indicative of fatal and non
fatal cardiovascular events. It was hypothesised that this risk
indicator could become a useful method both in clinical
practice and in screening for patients who will develop an
ischemic cardiomyopathy.
In another prospective study with a 7years follow-up in
the Cardiovascular Health Study elderly multi-ethnic popu-
lation, abnormalities in T-wave axis doubled the occurrence
of events and were correlated with both systolic and diastolic
blood pressure, as well as with ST abnormalities and with
silent myocardial infarction.5
A more recent prospective study, with a 12years follow-
up on a younger cohort (52years) and with a low incident
rate of cardiovascular events did not ﬁnd a signiﬁcant
relation between abnormal T-wave axis and event occur-
rence, in contrast with previous studies.6
A recent epidemiological report from the United States
showed that abnormal T-wave axis shift is also indepen-
dently associated with metabolic syndrome (MetS), sug-
gesting the need to perform a careful electrocardiographic
screening among persons with MetS for early detection of
abnormal T-wave axis in clinical practice to prevent severe
and often fatal arrhythmias.7
MetS is a cluster of cardiovascular risk factors which has
been affecting millions of people worldwide. In the United
States approximately one-quarter of people are affected by
MetS and according to the latest data on the obesity
pandemic the incidence is likely to rise.8 Similar ﬁgures
have been reported in Europe and in particular in Southern
European countries where the prevalence of MetS is
reaching worrying levels. MetS has been associated with a
2-fold increase in cardiovascular disease and a 1.5-fold
increase in all-cause mortality.9
In this work we report the results of an analysis on T-wave
axis deviation from the frontal plane (TDev) and its
relationship with MetS and MetS components as assessed
in a large community adult sample population from central
Italy; as a secondary endpoint the estimated risk of CVD
associated with TDev on the same sample population has
been evaluated.
Methods
The cohort of the Moli-sani Study was randomly recruited
between March 2005 and April 2010 in the Molise region
from City Hall registries by multistage sampling across the
two recruiting centres.10 A total of 24,325 subjects were
enrolled by accurately trained research personnel. Admission
was carefully deﬁned and standardised and included a
structured digitalized questionnaire administered to collect
personal and clinical information.
The set of clinical data collected included a standard 12-
lead resting electrocardiogram (ECG) which was acquired
with a Cardiette®ar2100-view electrocardiograph (Cardio-
line). Digital ECG waveforms were stored in a public domain
standard (SCP format) and subsequently exported and
processed by a dedicated on-screen computer application11
which embeds a proprietary measuring tool and the University
of Glasgow 12-Lead ECG diagnostic algorithm.12
Metabolic syndrome (MetS) was deﬁned based on the
presence of one to ﬁve components (see Table 2 for details)
according to the Adult Treatment Panel III criteria.13
Subjects were excluded in the presence of at least one of
the following conditions: altered QRS duration (n=1250),
incomplete questionnaire (n=235), history of CVD (n=
1140), left ventricular hypertrophy (n=1141), or T-axis
value uncomputed because of noise (n=195), or at least one
MetS component missing (n=184). A total of 20,885
subjects (86%), 11,143 women (mean age 55±11) and
9742 men (mean age 55±11) were analyzed. The value of
T-wave axis in the frontal plane was categorized in three
groups as follows2:
- Normal: 15°≤TDev≤75°
- Borderline: 75°bTDev≤105° or −15°≤TDevb15°
- Abnormal: -180°≤TDevb−15° or 105°bTDev≤180°
Generalized linear models were used for testing the asso-
ciation of the TDev classiﬁcation with general characteristics
of MetS. Multivariable logistic regression analysis was
applied to quantify the association of MetS or components of
MetS with status of borderline or abnormal TDev in com-
parison with normal conditions. Estimates of global indi-
vidual CVD risk were calculated applying the equations
deﬁned in the CUORE project.14,15
Results
General characteristics of men and women included in
the study are illustrated in Table 1 whereas Table 2
summarizes the results categorized by MetS components.
MetS was prevalent in 27% (n=2643) of men and in 24%
(n=2663) of women. TDev was categorized as normal in
74.5% of men and in 80.9% of women, borderline in 23.6%
and 17.3% and abnormal in 1.9% and 1.8%. In men, the
prevalence of borderline and abnormal TDev was higher in
the presence of MetS (26.6% vs. 22.1% and 2.5% vs. 1.7%,
respectively for borderline and abnormal TDev; pb0.0001,
Table 1a). The prevalence of normal TDev decreased from
84% to 66% when the number of MetS components
increased from zero to ﬁve (Table 2a), and each additional
MetS component increased the odds of having borderline or
abnormal TDev by 1.21. Similarly, in women, the
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prevalence of borderline or abnormal TDev was higher in
the presence of MetS (25% vs. 15% and 2.4% vs. 1.6%,
respectively for borderline and abnormal TDev; pb0.0001,
Table 1b). The prevalence of normal TDev decreased from
89% to 74% when the number of MetS components
increased from zero to ﬁve (Table 2b), and each additional
MetS component increased the odds of having borderline or
abnormal TDev by 1.31.
Table 1
Males and Females characteristics by MetS status.
MEN Metabolic Syndrome
Characteristics All 9742 Absent 7099 (73%) Present 2643 (27%) p-value Age adjusted
a
Age, years (sd) 55 (11) 54 (12) 57 (11) b.0001#
BMI, kg/m2 (sd) 28.2 (4.1) 27.1 (3.4) 31.1 (4.3) b.0001
Heart rate b/m 66 (10) 65 (10) 68 (11) b.0001
QRS complex duration, ms 91.1 (8) 91.0 (8) 91.2 (8) 0.21
T-wave axis deviation n, (%) b.0001
Normal 7256 (74.5) 5408 (76.2) 1848 (69.9)
Borderline 2301 (23.6) 1572 (22.1) 729 (27.6)
Abnormal 185 (1.9) 119 (1.7) 66 (2.5)
WOMEN Metabolic syndrome
Characteristics All 11,143 (100%) Absent 8480 (76%) Present 2663 (24%) p-value Age adjusted
b
Age, years (sd) 54 (11) 53 (11) 60 (11) b.0001#
BMI, kg/m2 (sd) 27.7 (5.3) 26.5 (4.7) 31.7 (5.1) b.0001
Heart rate b/m 69 (10) 68 (10) 70 (11) b.0001
QRS complex duration, ms 86.1 (8) 86.0 (8) 86.4 (7) 0.014
T-wave axis deviation n, % b.0001
Normal 9012 (80.9) 7078 (83.5) 1934 (72.6)
Borderline 1929 (17.3) 1264 (14.9) 665 (25.0)
Abnormal 202 (1.8) 138 (1.6) 64 (2.4)
Table 2
Metabolic syndrome components according to T-wave axis deviation in women.
MEN T- wave axis deviation
Characteristics Normal n=7256 (74%) Borderline n=2301 (24%) Abnormal n=185 (2%) p-value Age adjusted
a
Waist circumference ≥102cm 1795 (67%) 826 (31%) 69 (3%) b.0001
Triglycerides≥150mg/dl 2570 (73%) 864 (25%) 63 (2%) 0.11
HDL b40mg/dl 1064 (72%) 373 (25%) 29 (2%) 0.074
SBP≥130 or DBP≥85mm Hg 5545 (73%) 1893 (25%) 166 (2%) b.0001
Fasting glucose≥110mg/dl 1905 (71%) 697 (26%) 72 (3%) b.0001
Number of MetS components b.0001
0 938 (84%) 175 (16%) 6 (0.5%)
1 2335 (76%) 629 (21%) 50 (2%)
2 2135 (72%) 768 (26%) 63 (2%)
3 1227 (70%) 481 (27%) 44 (3%)
4 512 (71%) 195 (27%) 19 (3%)
5 109 (66%) 53 (32%) 3 (2%)
WOMEN T-wave axis deviation
Characteristics Normal n=9012 (81%) Borderline n=1929 (17%) Abnormal n=202 (2%) P-value Age adjusted
b
Waist circumference≥88cm 4894 (76%) 1392 (22%) 146 (2%) b.0001
Triglycerides≥150mg/dl 1528 (75%) 474 (23%) 40 (2%) b.0001
HDL b50mg/dl 1507 (76%) 435 (22%) 35 (2%) b.0001
SBP≥130 or DBP≥85mm Hg 5447 (78%) 1409 (20%) 159 (2%) b.0001
Fasting glucose≥110mg/dl 1111 (76%) 321 (22%) 39 (3%) b.0001
Number of MetS components b.0001
0 1884 (89%) 201 (10%) 21 (1%)
1 2549 (86%) 388 (13%) 38 (1%)
2 2645 (78%) 675 (20%) 79 (2%)
3 1242 (73%) 418 (25%) 37 (2%)
4 538 (71%) 196 (26%) 23 (3%)
5 154 (74%) 51 (24%) 4 (2%)
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After adjustment for age, there was a signiﬁcant
association between TDev and cardiovascular risk score at
10years, in both genders. In men, after further adjustment for
cigarette smoking, social status, physical activity and QRS
duration, TDev was associated with an increase in the risk to
develop a cardiovascular event in 10years of 1.38 and 4.44,
respectively for borderline and abnormal TDev. In women,
the association reached signiﬁcant levels only in univariate
analysis (estimated risk at 10years 1.37 and 1.78, respec-
tively for borderline and abnormal TDev).
4. Discussion
In this work, the epidemiological usefulness of T-wave
axis in the frontal plane in a large Italian Mediterranean
cohort has been analyzed with the primary goal to critically
compare the incidence of deviations of this parameter with
that observed on studies on other populations, and with
special emphasis on metabolic syndrome. The potential
incremental value of TDev as an alternative risk factor of
cardiovascular events has also been assessed.
Our ﬁndings conﬁrm what was previously reported, i.e.
they demonstrate a signiﬁcant association between an ab-
normal TDev with MetS and its single components.5 In
addition, our analysis showed that an abnormal TDev is
strongly related to the estimated cardiovascular risk at
10years, as calculated with the CUORE algorithm.14,15
Table 3 summarized the results from ﬁve studies
(including our report): the four manuscripts in which TDev
was quantiﬁed concur on the percentage of apparently
healthy subjects with abnormal TDev which increases from
about to 2%–3% in middle-aged adults (about 50years) to
10% in elderly (age about 70years). Of note, one of the
studies referenced in the Table is a recent research on the
Nhanes cohort of a relatively young and bi-ethnic popula-
tion, which demonstrated a graded relation between T-wave
abnormalities on the frontal axis and metabolic syndrome
occurrence, as well as with individual components of the
metabolic syndrome.7 This result seems to indicate that in a
percentage of patients with MetS an abnormality on the
surface ECG could predict preclinical ischemia or myocar-
dial remodeling predisposing to potentially dangerous
arrhythmias. Our results, obtained in a larger cohort of
Caucasians from the Mediterranean region are in agreement
with results obtained in the NHANES study on an American
population, with respect to both the reported incidence
of abnormal TDev and the signiﬁcant linearly-related in-
crease of TDev abnormalities associated with the presence
of one or more component of MetS. The total incidence of
abnormal TDev associated with MetS observed in the
NHANES cohort was about 5%7 which is about double than
that observed in our study (Table 1); this difference could be
related to the genetically different population but also to the
higher incidence of cardiovascular disease in North America
as compared to the Mediterranean region.
In our population, the baseline percentage of abnormal
TDev was found to be around 2%, which is close to the
value (3%) observed on the NHANES cohort.7 This
ﬁnding is consistent with the fact that both the Moli-sani
and the Nhanes are consistently younger populations than
that described in the Rotterdam Heart Study where the
incidence of abnormal TDev reached 10%.4 Some of the
differences between these ﬁndings are probably related to
ethnicity, although the prevalence of an abnormal TDev
directly related to race had not yet been demonstrated.
Variants related to the methodology to determine T-wave
axis, and the interaction between this parameter and other
ECG measurements could also explain different results in
the literature.
T-wave axis deviation reﬂects abnormal ventricular
repolarization which is indicative of subclinical myocardial
pathology. This parameter has been associated with an
increased risk of coronary heart disease (CHD) and total
mortality, independent of other cardiovascular factors and
particularly in elderly populations.4
In four of the studies reported in Table 3, TDev resulted in
an effective risk indicator, probably a marker of preclinical
heart disease, whereas in one it did not provide a better
stratiﬁcation as compared to traditional risk factors.6 Results
from Rautaharju et al. suggest that TDev is a marker for
subclinical disease and an independent indicator for the risk
of incident CHD events in older men and women.5
The different occurrence of fatal and non fatal events is
obviously related to the age of the population but it could
also be explained by different genetic substrate, environ-
mental pattern and by the selection of the cohort (with or
without exclusion of patients affected by coronary artery
disease). What seems clear when comparing different studies
is that the incidence of abnormal TDev increases when the
mean age of the cohort evaluated is higher (Table 3), and
that in both American and European cohorts an abnormal
TDev is related with the metabolic syndrome and with each
of its component. 7,9 This ﬁnding seems to favor a
pathogenetic interpretation of the mechanism determining
the fatal and non fatal occurrence of events over time in
patients with abnormal TDev at enrollment.
If conﬁrmed, it would be of great interest to know
whether an altered TDev in patients with MetS can be a more
Table 3
Study cross-comparison on TDev and cardiovascular risk associated with TDev.
# subjects Mean age (years) Race %abn. TDev Cardiovascular risk
Kors 5781 69 Caucasian 10.5 4.04
Vaidean 12,256 54 Caucasian and Afro-American uncomputed non significant
Rautahariu 4173 72 multi-ethnic 12 2.88
Faramawi 3810 59 Caucasian, black, others 2.97 not inspected
Assanelli 24,325 55 Caucasian 1.8–2.8 N 1.5
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critical indicator of heart disease, than the presence of MetS
with normal TDev. The knowledge of a mechanism in
patients with MetS and TDev abnormalities could provide
better understand whether an ischemic or arrhythmic
substrate could be the trigger of events in both conditions.
Patients with an abnormal T wave axis should be
evaluated with Holter monitoring to detect arrhythmias,
with ECG stress-test to detect silent ischemic events and
with echocardiogram to exclude ventricular remodeling.
This in-depth screening should help to understand the cause
of T-wave deviation not only on an epidemiological
perspective, but with a clinical individually tailored
evaluation. The better knowledge of the causes of T-wave
axis abnormalities could allow physicians to effectively
treat individual patients to avoid or delay the occurrence of
major cardiovascular events.
Acknowledgments
The Authors thank Associazione Cuore-Sano (Campo-
basso, Italy), IL Instrumentation-Laboratory (Milano, Italy),
Derby-Blue (San Lazzaro di Savena, Bologna, Italy), Caffè
Monforte (Campobasso, Italy) and Sepinia SpA (Sepino,
Italy) for their support to the MOLI-SANI project.
References
1. Savelieva I, Yi G, Guo X, Hnatkova K, Malik M. Agreement and
reproducibility of automatic versus manual measurement of QT interval
and QT dispersion. Am J Cardiol 1998;81:471.
2. Funck-Brentano C, Jaillon P. Rate-corrected QT interval: techniques
and limitations. Am J Cardiol 1993;72:B17.
3. Auer R, Bauer DC, Marques-Vidal P, et al. Association of major and
minor ECG abnormalities with coronary heart disease events. JAMA
2012;307:1497.
4. Kors JA, de Bruyne MC, Hoes AW, et al. T-axis as an indicator of risk
of cardiac events in elderly people. Lancet 1998;352:601.
5. Rautaharju PM, Nelson JC, Kronmal RA, et al. Usefulness of T-axis
deviation as an independent risk indicator for incident cardiac events in
older men and women free from coronary heart disease (the Cardio-
vascular Health Study). Am J Cardiol 2001;88:118.
6. Vaidean GD, Rautaharju PM, Prineas RJ, et al. The association of
spatial T wave axis deviation with incident coronary events. The ARIC
cohort. BMC Cardiovasc Disord 2005;5:1.
7. Faramawi MF, Sall M, Abdul Kareem MY. The association of the
metabolic syndrome with T-wave axis deviation in NHANES III. Ann
Epidemiol 2008;18:702.
8. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome
among US adults: findings from the third National Health and Nutrition
Examination Survey. JAMA 2002;287:356.
9. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and
cardiovascular risk a systematic review and meta- analysis. J Am Coll
Cardiol 2010;56:1113.
10. Iacoviello L, Bonanni A, Costanzo S, et al. The Moli-sani Project, a
randomized, prospective cohort study in the Molise region in Italy;
design, rationale and objectives. Italian J. Public Health 2007;4:110.
11. Badilini F, Sarapa N. Implications of methodological differences in
digital electrocardiogram interval measurement. J Electrocardiol 2006;
39:S152.
12. Macfarlane PW, Devine B, Latif S, McLaughlin S, Shoat DB, Watts
MP. Methodology of ECG interpretation in the Glasgow program.
Methods Inf Med 1990;29:354.
13. Executive summary of the third report of the National Cholesterol
Education Program (NCEP) Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel
III). JAMA 2001;285:2486.
14. http://www.cuore.iss.it/cuore_exe/cuore_exe.asp.
15. Ferrario M, Chiodini P, Chambless LE, et al. Prediction of coronary
events in a low incidence population. Assessing accuracy of the CUORE
Cohort Study prediction equation. Int J Epidemiol 2005;34:413.
550 D. Assanelli et al. / Journal of Electrocardiology 45 (2012) 546–550
